NK cell-mediated targeting of human ovarian cancer and possibilities for immunotherapy: [review]
ARBS annu. rev. biomed. sci
;
13(n.esp): 23-29, 2011.
Article
in English
| LILACS
| ID: lil-619905
ABSTRACT
A better understanding of the NK cellreceptor-ligand interaction opened possibilities for new therapeutic strategies. The well known mismatch KIR/HLA interaction is of great importance for NK cell stimulation. Lately, the interaction of the activating receptorDNAM-1 with its ligand PVR, has been highlighted in many ovarian carcinoma studies. Autologous andallogeneic NK cells, along with monoclonal antibodies, have been tested in current immunotherapies. Thisreview presents information on NK cell receptor-ligand interactions and its possibilities for NK-basedimmunotherapy against ovarian cancer.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Ovarian Neoplasms
/
Killer Cells, Natural
/
Immunotherapy
Limits:
Humans
Language:
English
Journal:
ARBS annu. rev. biomed. sci
Journal subject:
Biology
Year:
2011
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Campinas University/BR
Similar
MEDLINE
...
LILACS
LIS